Rakesh Mehta

First of all, congratulations team for the fabulous set of numbers. I have 2 queries. One is that the Biologics business contributes just 11%, which is close to INR52 crores. What would be the growth trajectory going forward? This is one. Should I go for next question?

Okay. And what would be the contribution from the India and outside-India businesses, in case you are thinking about Biologics?

Okay. Second query is th e current EBITDA is around 29%. First of all, how sustainable is it? And what would be the trajectory going forward in case if you can throw some light?